PTCH1 and medulloblastoma: Taken together, our data suggest that the strongly enhanced ISR via GADD34 homozygous mutation significantly promotes pre-malignant GCP apoptosis and reduces the number of hyperplastic lesions in young Ptch1+/− mice, resulting in the significantly decreased incidence of medulloblastoma in adult Ptch1+/− mice.